Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors
- PMID: 11339895
- DOI: 10.1089/104303401750148720
Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors
Abstract
Although growth factor proteins display potent tissue repair activities, difficulty in sustaining localized therapeutic concentrations limits their therapeutic activity. We reasoned that enhanced histogenesis might be achieved by combining growth factor genes with biocompatible matrices capable of immobilizing vectors at delivery sites. When delivered to subcutaneously implanted sponges, a platelet-derived growth factor B-encoding adenovirus (AdPDGF-B) formulated in a collagen matrix enhanced granulation tissue deposition 3- to 4-fold (p < or = 0.0002), whereas vectors encoding fibroblast growth factor 2 or vascular endothelial growth factor promoted primarily angiogenic responses. By day 8 posttreatment of ischemic excisional wounds, collagen-formulated AdPDGF-B enhanced granulation tissue and epithelial areas up to 13- and 6-fold (p < 0.009), respectively, and wound closure up to 2-fold (p < 0.05). At longer times, complete healing without excessive scar formation was achieved. Collagen matrices were shown to retain both vector and transgene products within delivery sites, enabling the transduction and stimulation of infiltrating repair cells. Quantitative PCR and RT-PCR demonstrated both vector DNA and transgene mRNA within wound beds as late as 28 days posttreatment. By contrast, aqueous formulations allowed vector seepage from application sites, leading to PDGF-induced hyperplasia in surrounding tissues but not wound beds. Finally, repeated applications of PDGF-BB protein were required for neotissue induction approaching equivalence to a single application of collagen-immobilized AdPDGF-B, confirming the utility of this gene transfer approach. Overall, these studies demonstrate that immobilizing matrices enable the controlled delivery and activity of tissue promoting genes for the effective regeneration of injured tissues.
Similar articles
-
Adenovirus encoding human platelet-derived growth factor-B delivered in collagen exhibits safety, biodistribution, and immunogenicity profiles favorable for clinical use.Mol Ther. 2004 May;9(5):699-711. doi: 10.1016/j.ymthe.2004.02.018. Mol Ther. 2004. PMID: 15120331
-
Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing.J Invest Dermatol. 1999 Sep;113(3):375-83. doi: 10.1046/j.1523-1747.1999.00705.x. J Invest Dermatol. 1999. PMID: 10469337
-
FGF2-Targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation.Mol Ther. 2000 Aug;2(2):153-60. doi: 10.1006/mthe.2000.0102. Mol Ther. 2000. PMID: 10947943
-
Role of platelet-derived growth factor in wound healing.J Cell Biochem. 1991 Apr;45(4):319-26. doi: 10.1002/jcb.240450403. J Cell Biochem. 1991. PMID: 2045423 Review.
-
Clinical protocol: Phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer.Wound Repair Regen. 2000 Nov-Dec;8(6):480-93. doi: 10.1046/j.1524-475x.2000.00480.x. Wound Repair Regen. 2000. PMID: 11208175 Review.
Cited by
-
Integration of drug, protein, and gene delivery systems with regenerative medicine.Drug Deliv Transl Res. 2015 Apr;5(2):168-86. doi: 10.1007/s13346-013-0165-8. Drug Deliv Transl Res. 2015. PMID: 25787742 Free PMC article. Review.
-
ECM turnover-stimulated gene delivery through collagen-mimetic peptide-plasmid integration in collagen.Acta Biomater. 2017 Oct 15;62:167-178. doi: 10.1016/j.actbio.2017.08.038. Epub 2017 Sep 1. Acta Biomater. 2017. PMID: 28865990 Free PMC article.
-
Advanced Strategies for Articular Cartilage Defect Repair.Materials (Basel). 2013 Feb 22;6(2):637-668. doi: 10.3390/ma6020637. Materials (Basel). 2013. PMID: 28809332 Free PMC article. Review.
-
Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors.Mol Ther. 2004 Apr;9(4):519-26. doi: 10.1016/j.ymthe.2004.01.016. Mol Ther. 2004. PMID: 15093182 Free PMC article.
-
Matrices and scaffolds for DNA delivery in tissue engineering.Adv Drug Deliv Rev. 2007 May 30;59(4-5):292-307. doi: 10.1016/j.addr.2007.03.017. Epub 2007 Apr 14. Adv Drug Deliv Rev. 2007. PMID: 17512630 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources